SCHEMBL5233129

SCHEMBL5233129

CC(C)N(c1nn(-c2ccc(N)cc2)cc1C(=O)O)C(=O)[C@H]1CC[C@H](C)CC1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.34
CA9 Q16790 1/20 0.34
ESRRA P11474 1/20 0.32
KDM5B Q9UGL1 1/20 0.31
USP2 O75604 2/20 0.30
L3MBTL1 Q9Y468 3/20 0.30
KDM4E B2RXH2 2/20 0.30
ALDH1A1 P00352 2/20 0.30
MEN1 O00255 1/20 0.30
POLB P06746 1/20 0.30
MAPT P10636 1/20 0.30
RECQL P46063 1/20 0.30
KMT2A Q03164 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
ATM Q13315 1/20 0.30
HPGD P15428 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
HSD17B10 Q99714 1/20 0.30
PARP1 P09874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5233141 1.00 CA12 (0.34) CA12CA9ESRRAKDM5BUSP2
SCHEMBL5229276 0.92 LMNA (0.35) CA12CA9ESRRAL3MBTL1ALDH1A1
SCHEMBL5229268 0.92 LMNA (0.35) CA12CA9ESRRAL3MBTL1ALDH1A1
SCHEMBL5233118 0.91 CA12 (0.33) CA12CA9ESRRAKDM5BUSP2
SCHEMBL5233595 0.91 ALDH1A1 (0.36) CA12CA9KDM5BALDH1A1MEN1
SCHEMBL5233096 0.91 CA12 (0.33) CA12CA9ESRRAKDM5BUSP2
SCHEMBL5233587 0.91 ALDH1A1 (0.36) CA12CA9KDM5BALDH1A1MEN1
SCHEMBL5230218 0.91 ALDH1A1 (0.39) KDM5BUSP2L3MBTL1KDM4EALDH1A1
SCHEMBL5230228 0.91 ALDH1A1 (0.39) KDM5BUSP2L3MBTL1KDM4EALDH1A1
SCHEMBL5232558 0.90 CA12 (0.35) CA12CA9KDM5BKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730116-B1 4-CARBOX PYRAZOLE DERIVATES USEFUL AS ANTI-VIRAL AGENTS SMITHKLINE BEECHAM CORP (US) 2007-09-05 EP claimed
US-20070167507-A1 4-Carbox pyrazole derivatives useful as anti-viral agents GLAXO GROUP LIMITED (GB) 2007-07-19 US claimed
EP-1730116-B1 4-CARBOX PYRAZOLE DERIVATES USEFUL AS ANTI-VIRAL AGENTS SMITHKLINE BEECHAM CORP (US) 2007-09-05 EP disclosed
US-20070167507-A1 4-Carbox pyrazole derivatives useful as anti-viral agents GLAXO GROUP LIMITED (GB) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167507-A1 4-Carbox pyrazole derivatives useful as anti-viral agents HAVCR2, RPL35, ZC3HAV1L CA12 4270/4885CA9 3715/4885ESRRA 2268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.